KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Helmerich & Payne (HP) Cash & Equivalents (2016 - 2025)

Helmerich & Payne (HP) has disclosed Cash & Equivalents for 17 consecutive years, with $247.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 36.81% to $247.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $247.2 million, a 36.81% decrease, with the full-year FY2025 number at $196.8 million, down 9.43% from a year prior.
  • Cash & Equivalents was $247.2 million for Q4 2025 at Helmerich & Payne, up from $196.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $917.5 million in Q3 2021 to a low of $159.7 million in Q1 2023.
  • A 5-year average of $272.2 million and a median of $219.0 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 88.06% in 2021, then tumbled 74.7% in 2022.
  • Helmerich & Payne's Cash & Equivalents stood at $234.2 million in 2021, then dropped by 2.14% to $229.2 million in 2022, then decreased by 6.58% to $214.1 million in 2023, then skyrocketed by 82.71% to $391.2 million in 2024, then tumbled by 36.81% to $247.2 million in 2025.
  • Per Business Quant, the three most recent readings for HP's Cash & Equivalents are $247.2 million (Q4 2025), $196.8 million (Q3 2025), and $166.1 million (Q2 2025).